Panama’s national NBS program was established in 2007 to detect PKU, CH, GAL, CAH, hemoglobinopathies, sickle cell disease, and glucose-6-phosphate dehydrogenase deficiency (No, 2009; Sánchez, 2021). This evidence concerns the gene GAL and sickle cell disease.